Abraxis and AstraZeneca are partnering to support disease state educational programs that help address the unmet needs of health care professionals. We also recognize the importance of upholding the integrity of medical education, and hope that the following information will be a valuable resource to individuals and organizations in the completion of successful grant applications.

Educational Interest

Independent educational programs supported by Abraxis and AstraZeneca will be consistent with one of the following areas of educational interest:

• Breast cancer
• Lung Cancer
• Melanoma
• Ovarian/Gynecologic Cancers
• Prostate Cancer
• Upper GI (pancreatic) Cancer
• Head & Neck Cancer
• General Oncology
• Nanotechnology

Educational Intent

When evaluating grant applications for educational programs, the Review Team will look for those programs whose content aligns with the following statements of educational intent:

• The program supports an educational need by providing valuable disease state information to enhance patient care
• The program will help develop or increase knowledge and skills that healthcare professionals use to provide services for the public and patients
• The program will help develop or increase knowledge of novel and emerging therapies based on a documented unmet need
• The program will include global and US research perspectives, including molecular correlations
• The program incorporates EBM (Evidence Based Medicine) related to core objectives, as well as methodology itself
• The program will assist physicians in carrying out their diagnosis and treatment strategies more effectively and efficiently
• The program will help develop or increase patient knowledge of disease state and treatment options